Authors: XIAO H MAZUMDAR M BAJORIN DF SAROSDY M VLAMIS V SPICER J FERRARA J BOSL GJ MOTZER RJ

Citation: H. Xiao et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH GOOD-RISK GERM-CELL TUMORS TREATED WITH ETOPOSIDE AND CISPLATIN, Journal of clinical oncology, 15(7), 1997, pp. 2553-2558

Authors: SOLOWAY MS SCHELLHAMMER P SHARIFI R VENNER P PATTERSON AL SAROSDY M VOGELZANG N JONES J KOLVENBAG G

Citation: Ms. Soloway et al., A CONTROLLED TRIAL OF CASODEX(TM) (BICALUTAMIDE) VS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY IN PATIENTS WITH ADVANCED PROSTATE-CANCER, European urology, 29, 1996, pp. 105-109

Authors: SCHELLHAMMER P SHARIFI R BLOCK N SOLOWAY M VENNER P PATTERSON AL SAROSDY M VOGELZANG N JONES J KOLVENBAG G

Citation: P. Schellhammer et al., MAXIMAL ANDROGEN BLOCKADE FOR PATIENTS WITH METASTATIC PROSTATE-CANCER - OUTCOME OF A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONEANALOGUE THERAPY, Urology, 47(1A), 1996, pp. 54-60

Authors: VANDENBERG C GUAN XY VONHOFF D JENKINS R BITTNER M GRIFFIN C KALLIONIEMI O VISAKORPI T MCGILL J HERATH J EPSTEIN J SAROSDY M MELTZER P TRENT J

Citation: C. Vandenberg et al., DNA-SEQUENCE AMPLIFICATION IN HUMAN PROSTATE-CANCER IDENTIFIED BY CHROMOSOME MICRODISSECTION - POTENTIAL PROGNOSTIC IMPLICATIONS, Clinical cancer research, 1(1), 1995, pp. 11-18

Authors: SCHELLHAMMER P SHARIFI R BLOCK N SOLOWAY M VENNER P PATTERSON AL SAROSDY M VOGELZANG N JONES J KOLVENBAG G

Citation: P. Schellhammer et al., A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY, IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Urology, 45(5), 1995, pp. 745-752